EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, AVBP: Arrivent Biopharma Inc

21 Nov 25 15:59
LAST:

20.31

CHANGE:
 0.29		OPEN:
19.88		HIGH:
20.60		ASK:
0.00		VOLUME:
84.8K
CHG(%):
1.45		PREV:
20.06		LOW:
19.88		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Nov 2519.8820.6019.8820.35164.6K
20 Nov 2520.3421.0719.9920.06192.4K
19 Nov 2520.0920.4519.9320.03136.2K
18 Nov 2520.6220.8620.0020.21153.1K
17 Nov 2520.7421.1120.0320.69270.6K
14 Nov 2519.4621.0019.4220.69456.7K
13 Nov 2519.9920.2419.1019.68249.8K
12 Nov 2519.4420.4819.2720.20366.7K
11 Nov 2518.5119.6718.0419.38329.3K
10 Nov 2518.6718.9517.8118.60387.7K

PROFILE

Name:Arrivent Biopharma Inc
About:ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. The company's lead development candidate is firmonertinib, a tyrosine kinase inhibitor that is being evaluated in multiple clinical trials across a range of epidermal growth factor receptor mutations (EGFRm) in non-small cell lung cancer (NSCLC), including a Phase 3 clinical trial for treatment of patients with advanced or metastatic EGFRm NSCLC with exon 20 insertion mutations, as well as Phase 1b clinical trials to treat NSCLC patients with activating EGFRm, including P-loop and-alpha-c-helix compressing (PACC) mutations, and classical EGFRm NSCLC patients. It is also developing ARR-217, an antibody drug conjugate (ADC) for the treatment of gastrointestinal cancers; and ARR-002 for solid tumors. The company has strategic collaborations with Aarvik Therapeutics Inc., Shanghai Allist Pharmaceuticals Co., Ltd., Beijing InnoCare Pharma Tech Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd., and Lepu Biopharma Co. Ltd. ArriVent BioPharma, Inc. was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
Sector:Healthcare
Industry:Biotechnology
Address:18 Campus Boulevard, Newtown Square, PA, United States, 19073
Website:https://arrivent.com
CIK:0001868279
ISIN:US04272N1028
FIGI:BBG011N37VQ0

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-6.88 
Forward P/E:-6.31 
PEG Ratio:-0.18 
Price to Book:2.64 
Return on Assets:-0.23 
Return on Equity:-0.50 
EPS Ratio:-4.00 
Shares:40.57M 
Market Cap:823.75M 

TECHNICAL INDICATORS

MA5:20.270.2%
MA10:19.991.6%
MA20:19.305.2%
MA50:19.166.0%
MA100:19.563.8%
MA200:20.501.0%
STO9:56.07
STO14:75.20
RSI14:70.96 
WPR14:-12.85 
MTM14:1.64
ROC14:0.09 
ATR:1.16 
Week High:21.114.0%
Week Low:19.424.6%
Month High:21.114.0%
Month Low:17.001.0%
Year High:30.4149.7%
Year Low:15.4731.3%